Read + Share
Amedeo Smart
Independent Medical Education
Bouwmeester RN, van de Kar NCAJ, Wetzels JFM. Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome. Kidney Int 2021;100:265-268.PMID: 33675845
Email
LinkedIn
Facebook
Twitter
Privacy Policy